We are live on ! Find out more
SXL

Summit X LLC Portfolio holdings

AUM $536M
1-Year Est. Return 15.36%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+15.36%
3 Year Est. Return
+62.88%
5 Year Est. Return
+106.61%
10 Year Est. Return
–
AUM
$396M
AUM Growth
+$31.8M
Cap. Flow
+$6.89M
Cap. Flow %
1.74%
Top 10 Hldgs %
29.3%
Holding
272
New
11
Increased
129
Reduced
95
Closed
8

Top Buys

1
IXG icon
iShares Global Financials ETF
IXG
+$2.46M
2
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$1.42M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$970K
4
COMT icon
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
+$936K
5
RBLX icon
Roblox
RBLX
+$858K

Top Sells

1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.65M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$1.46M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.24M
4
IXN icon
iShares Global Tech ETF
IXN
+$1.17M
5
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$792K

Sector Composition

1 Technology 13.07%
2 Consumer Discretionary 8.85%
3 Financials 8.19%
4 Communication Services 6.61%
5 Healthcare 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDOC icon
251
Teladoc Health
TDOC
$1.7B
$203K 0.05%
1,205
-25
-2% -$4.05K
HR icon
252
Healthcare Realty
HR
$7.39B
$201K 0.05%
11,560
-1,560
-12% -$44.1K
KOPN icon
253
Kopin
KOPN
$706M
$134K 0.03%
16,300
– –
GERN icon
254
Geron
GERN
$924M
$126K 0.03%
90,012
– –
XXII
255
22nd Century Group
XXII
$1.49M
– –
0
– –
TRVN
256
DELISTED
Trevena, Inc.
TRVN
$103K 0.03%
99
– –
LCTX icon
257
Lineage Cell Therapeutics
LCTX
$289M
$82K 0.02%
29,000
-3,000
-9% -$7.76K
ISEE
258
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$81K 0.02%
12,850
– –
LYG icon
259
Lloyds Banking Group
LYG
$86.6B
$48K 0.01%
17,616
+540
+3% +$1.39K
SER icon
260
Serina Therapeutics
SER
$31.9M
$32K 0.01%
583
– –
DNN icon
261
Denison Mines
DNN
$2.55B
$26K 0.01%
22,000
– –
PTN
262
Palatin Technologies
PTN
$16.2M
$21K 0.01%
28
– –
NMTR
263
DELISTED
9 Meters Biopharma
NMTR
$17K ﹤0.01%
765
-300
-28% -$7.37K
BIOL
264
DELISTED
Biolase, Inc.
BIOL
$7K ﹤0.01%
4
– –
CASY icon
265
Casey's General Stores
CASY
$31.8B
– –
-930
Closed -$201K
CCD
266
Calamos Dynamic Convertible & Income Fund
CCD
$717M
– –
-12,790
Closed -$411K
DKNG icon
267
DraftKings
DKNG
$12.4B
– –
-3,517
Closed -$215K
IHI icon
268
iShares US Medical Devices ETF
IHI
$3.03B
– –
-26,238
Closed -$1.46M
LITE icon
269
Lumentum
LITE
$57B
– –
-3,703
Closed -$337K
LQD icon
270
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
– –
-12,596
Closed -$1.65M
MJ icon
271
Amplify Alternative Harvest ETF
MJ
$105M
– –
-1,210
Closed -$333K
QCLN icon
272
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$674M
– –
-5,474
Closed -$375K
7 8 9 10
11

Similar funds

WCWM
Wooster Corthell Wealth Management Glastonbury, Connecticut $540M AUM 11.84% 1-Year Est. Return
FGC
Financial Gravity Companies Lakeway, Texas $509M AUM
NC
NBW Capital Boston, Massachusetts $464M AUM 21.25% 1-Year Est. Return
MC
Montag & Caldwell Atlanta, Georgia $457M AUM 20.19% 1-Year Est. Return
PA
Parkside Advisors Berkeley, California $455M AUM 11.43% 1-Year Est. Return
TSWM
Tyler-Stone Wealth Management Beachwood, Ohio $621M AUM 25.44% 1-Year Est. Return
JWCA
J.W. Coons Advisors Columbus, Ohio $442M AUM 16.25% 1-Year Est. Return
BC
Belmont Capital Los Angeles, California $657M AUM 33.14% 1-Year Est. Return

Summit X LLC's Q2 2021 Portfolio in Review

As of Q2 2021, Summit X LLC held 272 positions worth $396M, up 8.7% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Summit X LLC's Q2 2021 filing shows 11 new, 129 increased, 95 reduced and 8 closed positions. Its largest new stake was iShares Global Financials ETF: 31,590 shares worth $2.45M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.65M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Summit X LLC's largest Q2 2021 buy was iShares Global Financials ETF: 31,590 shares worth $2.45M.
  • Summit X LLC added most to iShares Russell 1000 Growth ETF in Q2 2021, an estimated $1.42M increase.
  • Summit X LLC's biggest Q2 2021 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $1.24M.
  • Summit X LLC fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2021, selling an estimated $1.65M.
  • Summit X LLC's ten largest holdings make up 29% of its $396M portfolio in Q2 2021.
  • Summit X LLC opened 11 new positions and closed 8 in Q2 2021.
  • Summit X LLC's portfolio value rose 8.7% quarter-over-quarter to $396M.

Based on Summit X LLC's 13F filing for Q2 2021, filed 16 Jul 2021.